Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novamind Inc (OP: NVMDF )

N/A UNCHANGED
Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novamind Inc

< Previous 1 2 3 Next >
Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies
Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics... 
Via Benzinga
Topics Death
Exposures Death
Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program
Novamind Inc. (OTCQB:NVMDF),... 
Via Benzinga
Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the... 
From Novamind Inc.
Via AccessWire
Topics Death
Exposures COVID-19 Death
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders
Novamind Inc. (OTCQB:NVMDF) a mental health compan... 
Via Benzinga
Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6
TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... 
From Novamind Inc.
Via AccessWire
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic model TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc.... 
From Novamind Inc.
Via AccessWire
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
- Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice - Total revenue of $1,857,750, +113% when compared to same period last year - Total working capital of... 
From Novamind Inc.
Via AccessWire
Novamind Unveils New Logo and Invests in Unified Brand
TORONTO, ON / ACCESSWIRE / November 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc
Via AccessWire
Psychedelic Medicine: Major Health Providers Including Blue Cross Now Cover Ketamine Treatments
Four major health insurance providers recently approved psychedelic medicine company Novamind Inc. (CSE: 
Via Benzinga
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona
TORONTO, ON / ACCESSWIRE / November 16, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness
TORONTO, ON / ACCESSWIRE / November 15, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... 
From Novamind Ventures Inc.
Via AccessWire
Novamind Enters New Lease Agreement Responding to Patient Demand
TORONTO, ON / ACCESSWIRE / November 12, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced... 
From Novamind Inc.
Via AccessWire
Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others
Compass Pathways reported 
Via Talk Markets
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors
Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind TORONTO, ON / ACCESSWIRE / November 10, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... 
From Novamind Inc.
Via AccessWire
Exposures Product Safety
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces... 
From Novamind Inc.
Via AccessWire
Novamind Reports FY2021 Financial Results and Operating Highlights
- Industry-leading revenue, $6,069,247 in FY2021 - Total working capital of $9,680,431 to fund operations­­ - Expanded network to six clinics and three clinical research sites - Contracted for eight... 
From Novamind Inc.
Via AccessWire
Exposures COVID-19
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. 
Via Talk Markets
Novamind Unveils Stealth Mode Investment in Alto Neuroscience
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased... 
From Novamind Ventures Inc.
Via AccessWire
Novamind Granted DEA Licenses for Psilocybin Research
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances TORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... 
From Novamind Inc.
Via AccessWire
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
The Week In Psychedelics 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
Novamind to Present at LD Micro and KCSA Conferences
TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... 
From Novamind Inc.
Via AccessWire
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
Psychedelic Medicine For End-Of-Life And Palliative Care Patients: Novamind Launches Treatment Program
Novamind (Canadian: NM) (OTCQB:NVMDF), a company in the ps... 
Via Benzinga
Novamind Launches New Psychedelic Palliative Care Program
Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illness TORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc.... 
From Novamind Inc.
Via AccessWire
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
The Week In Psychedelics: 
Via Benzinga
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapy TORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"... 
From Novamind Ventures Inc.
Via AccessWire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.